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Different cell types and multiple cellular connections characterize the human brain. Gene
expression analysis using a specific population of cells is more accurate than conducting
analysis of the whole tissue homogenate, particularly in the context of neurodegenerative
diseases, where a specific subset of cells is affected by the different pathology.
Due to the difficulty of obtaining homogenous cell populations, gene expression in
specific cell-types (neurons, astrocytes, etc.) has been understudied. To leverage the
use of archive resources of frozen human brains in studies of neurodegenerative
diseases, we developed and calibrated amethod to quantify cell-type specific—neuronal,
astrocytes—expression profiles of genes implicated in neurodegenerative diseases,
including Parkinson’s and Alzheimer’s diseases. Archive human frozen brain tissues
were used to prepare slides for rapid immunostaining using cell-specific antibodies.
The immunoreactive-cells were isolated by Laser Capture Microdissection (LCM). The
enrichment for a particular cell-type of interest was validated in post-analysis stage by
the expression of cell-specific markers. We optimized the technique to preserve the RNA
integrity, so that the RNA was suitable for downstream expression analyses. Following
RNA extraction, the expression levels were determined digitally using nCounter Single
Cell Gene Expression assay (NanoString Technologies®). The results demonstrated that
using our optimized technique we successfully isolated single neurons and astrocytes
from human frozen brain tissues and obtained RNA of a good quality that was suitable for
mRNA expression analysis. We present here new advancements compared to previous
reported methods, which improve the method’s feasibility and its applicability for a variety
of downstream molecular analyses. Our new developed method can be implemented in
genetic and functional genomic research of neurodegenerative diseases and has the
potential to significantly advance the field.
Keywords: neuron, astrocyte, post-mortem frozen human brain, Laser Capture Microdissection, RNA, gene
expression
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INTRODUCTION
The human brain is characterized by an immense number of cells
and cellular connections (Herculano-Houzel, 2014; von Bartheld
et al., 2016). Measuring the gene expression of a specific cell
type is crucial to understanding the intracellular gene networks
that underlie cellular phenotypes (Okaty et al., 2011) and trigger
specific neurodegenerative diseases. The gene expression profile
in a homogenous population of cells is more informative than
studying the whole tissue expression, particularly in the context
of brain diseases, where a specific subset of cells is affected
by the different pathologies (Galvin, 2004). However, studying
the human brain at a single cell level is limited by different
factors, such as, but not limited to, the accessibility of the tissues,
the quality of the post-mortem tissues and the feasibility of a
robust technique for collecting homogenous cell populations.
Brain banks provide a valuable collection of archive brains from
deceased subjects: both healthy donors and those affected by
neurodegenerative diseases (Kretzschmar, 2009). The samples
that are distributed from the brain banks are largely formalin-
fixed and frozen tissues. It is well known that the structure
and the chemistry of nucleic acids, particularly of RNA, may
be modified when using formalin (Evers et al., 2011). Formalin-
fixed tissues are widely used for different applications; however,
they provide low yields and quality of extractable DNA and
RNA (Srinivasan et al., 2002). Therefore, gene expression analysis
can be performed and reproduced more accurately using frozen
human brains as a source for experiments at both the tissue level
and the single-cell level. Recent advances in technology have
enabled the collection of specific cell-types. For example, Laser
Capture Microdissection (LCM) can be used to study the brain at
the level of cell types, such as specific-glia or neurons. LCM is a
powerful tool used to obtain a pure targeted cell subgroup quickly
and precisely under the microscope, successfully overcoming the
problem of whole tissue heterogeneity for molecular analysis.
In fact, LCM, in combination with rapid immunohistochemical
staining, allows the collection of individual cells from a piece of
tissue (Waller et al., 2012). The immunoreactive cells, collected
with the LCM, provide a sufficient amount of good quality RNA
for gene expression analysis.
Different procedures have been developed to provide
quantitative data on the gene expression of specific population
of cells (Bhargava et al., 2014). The nCounter Single Cell Gene
Expression assay (NanoString Technologies R©) is a digital-based
approach to measure mRNA expression and represents a recent
advancement in the field of gene expression analysis (Veldman-
Jones et al., 2015). The automated nCounter platform hybridizes
fluorescently labeled probes that are custom-designed and target
specific genes of interest. The reported probes, which bind to
specific RNA sequences, are then counted individually such that
the exact number of transcripts for a specific gene in a sample is
known. There are many advantages to single-count technology,
such as the ability to assess up to 800 target mRNA species
from one sample. The nCounter Single Cell Gene Expression
assay allows the profiling of gene expression from single cells or
as little as 10 pg of total RNA. Based on the amount of RNA,
this technology negates the need for amplification, and produces
sensitive measurements for even degraded RNA. Studies have
also shown that the sensitivity of target detection remains
impressive also at very low input RNA amounts (Veldman-Jones
et al., 2015).
Here, we present an optimized and improved method
that coupled the above-mentioned techniques: rapid
immunohistochemical staining, LCM, and NanoString
Technologies R©. This method will allow the collection of a
particular subset of immunoreactive cells from frozen human
tissues followed by evaluation of gene expression using a
customized gene panel. Specifically, we aim to describe in detail
the different steps of the method to highlight the principles,
advantages, and limitations of this procedure. We will also
discuss troubleshooting and suggest solutions to allow the
generation of reliable and reproducible data when using available
archive resources of frozen human tissues.
MATERIALS AND METHODS
Quality Control and Sample Selection
Rapidly autopsied, frozen human temporal cortex tissues were
obtained from the Joseph and Kathleen Bryan Brain Bank
(Duke University). Twenty-five subjects were selected with post-
mortem intervals (PMI) of <13 h. The project was approved
by the Duke Institutional Review Board (IRB). RNA Integrity
Number (RIN) evaluation was done using RNA extracts from
brain tissue. Brain samples that showed RIN values >7 were
selected for conducting the following steps of the method
introduced in this paper.
Sample Slide Preparation
Microscope slides (VWR Micro Slides Superfrost R© Plus White,
USA, 48311-703) were cleaned with RNase zap (Ambion,
USA, AM9780) and 100% ethanol (VWR, USA, 89125-188),
decontaminated under UV light for 30 min, and then chilled at
−20◦C until usage. Brain tissue samples were broken into smaller
sections (≤0.5 cm3) using a clean mortar and pestle chilled in
dry ice. Next, the brain pieces were embedded over dry ice
into disposable vinyl specimen cryomolds using Optimal Cutting
Temperature Compound (Sakura Finetek, CA, 4583) and held at
−80◦C. After 24 h, tissues from the molded blocks were sliced
onto the pre-cleaned microscope slides. Samples were sliced into
8 µm sections using the Microm HM 505 N Cryostat at −20◦C
utilizing High Profile Microtome Blades (Leica, USA, 1115454).
Slides with brain tissue slices were stored at −80◦C. All methods
were performed under RNase-free conditions.
RNA Extraction and RIN Analysis
Total cell collection step was performed to assess whether high
quality RNA can be preserved from each brain tissue sample
post-slide preparation. RNA samples were extracted from the
contents of the entire slide. Each tissue section on the slide was
dissolved using 100µL of lysis buffer from the Arcturus PicoPure
RNA Isolation Kit (Applied Biosystems, USA, 12204-01) and
gently scraped from the slide surface. RNA was extracted directly
from the slide following the manufacturer’s protocol along with
the addition of DNase I treatment (Qiagen, DE, 79254). The
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quantity of RNA was analyzed using a NanoDrop 8000 UV-
Vis spectrophotometer (Thermoscientific, UK, ND-8000). The
quality of the RNA was assessed on a 2100 Bioanalyzer (Agilent,
CA, G2943CA) using the RNA 6000 Pico Chip (Agilent, USA,
5067-1513). Samples above the upper limit of the qualitative
range for the Agilent RNA 6000 Pico Chip (50–5000 pg/µl), as
determined by the NanoDrop results, were diluted 20-fold with
elution buffer before analysis on the Bioanalyzer. All samples
with RIN values of <4.6, post-mounting and slicing, fail at this
step and were excluded from the next steps of the LCM isolation
for RNA analysis.
Rapid Immunohistochemical Staining
Slides were held in place using a pre-chilled slide holder block.
The holder block was submerged in ice throughout the staining
process to maintain the cool temperature of the slide with
the tissue section. Staining was performed rapidly using the
Vectastain ABCKit peroxidase enzyme system (Vector Labs, CA,
PK-4000). Prior to conducting the staining protocol we prepared
a 10X working solution by applying 50 µL of avidin/biotinalyted
enzyme complex (ABC) into 500µL of cold 1X Tris Buffered
Saline (TBS; Corning, 46-012-CM) and incubating for ∼30min.
The staining procedure was then performed. First, the tissue was
hydrated onto the slide using a series of cold (−20◦C) fresh
ethanol dilutions: 100% (1min) to 95% (15 s) to 75% (15 s).
Next, the tissue was blocked using a 2% normal goat serum in
1X TBS for 3 min. The primary and secondary antibodies were
diluted in the blocking solution. The primary antibody (Table 1)
was applied for 3 min and then rinsed twice with 1X TBS.
Tissue was incubated with anti-rabbit IgG secondary antibody
(5%) from the ABC kit for 3 min and then washed twice with
1X TBS. Next, the tissue was incubated with the ABC solution
for 3 min. During ABC incubation, a dilution of the enzyme
substrate was freshly prepared avoiding light exposure, using the
DAB (3,3 diaminobenzidine) Peroxidase Substrate Kit (Vector
Laboratories, CA, SK-4100). After ABC incubation, the tissue was
washed again with 1X TBS. The DAB solution was gently added
to the tissue slice. After ∼10 s, the slide was rinsed with RNase-
free laboratory grade water to halt the enzymatic reaction. The
slide was then immediately rinsed in the ethanol series for 15 s
each from 75 to 95 to 100%. Tissue section was then cleared in
xylene for 5min and air dried for 10min. Lastly, slides were taken
immediately to the LCM facility.
Laser Capture Microdissection (LCM)
LCM was performed using the ZEISS PALM Microbeam 4.2
Microscope system. Parameters were as follows: Exposure time,
50–120ms; Focus, 7000; Energy, 32%; Delta, 2, 12; Laser Speed,
79%;Objective, 63X. The procedure was performed in RNase-free
conditions. For visualization, the slide was fitted onto the Axio
TABLE 1 | Primary antibodies used to identify specific cells.
Antibody Isotype Specificity Supplier Dilution
Neurofilament Rabbit IgG Neurons ABCAM 1:200
GFAP Rabbit IgG Astrocytes ABCAM 1:600
Observer Z1 microscope stand and an adhesive cap (500 Opaque
version, ZEISS, DE, 415190) was attached onto the collector stage.
The corresponding PALM Robomover Z software was used to
position the cap over the desired tissue section on the slide.
Cells were visualized on the computer interface and manually
selected using the CenterRoboLPC function. Subsequently, the
microscope laser cut the tissue and catapulted the cells into the
hovering adhesive cap. From each used slide 60–200 cells were
collected. After microdissection, the adhesive caps were sterilely
removed from the plastic and placed into 100 µl aliquots of lysis
buffer (Ambion, LT, 8540G12). The cap and lysis buffer were
incubated at 42◦C for 30 min and then stored at −80◦C until
RNA extraction.
RNA Extraction and Pre-Nanostring
Technologies® Processing
For each tissue sample collected cells were combined in aliquots
of a total of 200 cells. RNA was extracted from each aliquot
of 200 cells using the Ambion RNAqueous-Micro Total RNA
Isolation kit following the manufacturer’s instructions. Samples
were incubated with DNase I (Qiagen, DE, 79254) for 15 min at
room temperature to control for DNA contamination. RNA was
eluted in 8 µl of Elution Solution and stored at−80◦C.
Six microliters of RNA were used for reverse-transcription
(RT) into complementary DNA (cDNA) using 2 µL of
SuperScript VILOMaster Mix (Invitrogen, 11755050), under the
following conditions: 10 min at 25◦C, 120min at 42◦C, and 5min
at 85◦C.Next,Multiple Target Enrichment (MTE) was performed
using specific primers (Table 2). Briefly, 1 µL of the pooled
MTE primers and 7 µL of PreAmp TaqMan (Applied Biosystem,
CA, 4384266) were added to the cDNA. MTE amplification was
carried out for 12 cycles under the following conditions: 10
min at 94◦C, 15 s at 94◦C, 4 min at 60◦C. The Pre-NanoString
TABLE 2 | Primers for MTE.
Gene Forward Reverse
ENO2 ATAAAAGGGGGTCCGTGG AACACTCCCCTCCATCCC
SYP CTCCCTGTCCCCTGAGGT CTCTCTACCCCAAGCCCC
NFLH GCTTTGGCCCAATTCCTT TCACCCCCTTCTTCCTCC
Synphilin GGAGTGCGTACGCTGGAT GGCTACGTGAACGGCACT
GFAP GCTGGAAGCCGAGAACAA CACATGGACCTGCTGTCG
B2M CTGGGTTTCATCCATCCG TCACATGGTTCACACGGC
SDHA AGGATCAGATTGTGCCCG CTCTCTACCCCAAGCCCC
LDHA CCTTGAGCCAGGTGGATG GTTGGTTGCATTGTTTGTATGT
CYC1 CTTCGCGGGGTAGTGTTG TCACAGCCGAATGCAGAG
EIF4A2 ACTGGCAAG ACAGCCACA CCAATGCAGGCATGACAA
GAPDH CCGCATCTTCTTTTGCGT TTTGCCATGGGTGGAATC
YWHAZ CCTGCCTTCAATTTTGATCC TGCTGCAGTAAATAGGATGAGG
ENO2, Enolase 2; SYP, Synaptophysin; NFLH, Neurofilament; GFAP, Glial Fibrillary
Acid Protein; B2M, Beta-2-Microglobulin; SDHA, Succinate Dehydrogenase Complex,
Subunit A; LDHA, Lactate Dehydrogenase A; CYC1, Cytochrome C-1; EIF4A2,
Eukaryotic Translation Initiation Factor 4A2; GAPDH, Glyceraldehyde-3-Phosphate
Dehydrogenase; YWHAZ, Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase
Activation Protein, Zeta.
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Technologies R© processing was performed the day before the
analysis and samples were kept at 4◦C overnight.
nCounter Single Cell Gene Expression
Assay (Nanostring Technologies®)
Gene expression was quantified using a digital approach by
nCounter Single Cell Gene Expression Assay (Nanostring
Tecnhologies R© http://www.nanostring.com/products/single_
cell). Each sample was hybridized in a strip tube by adding buffer
and a CodeSet of target-specific reporter and capture probes
(listed in Table 3) and the samples underwent solution phase
hybridization overnight at 65◦C. After hybridization, the strip
tubes containing the samples were loaded onto the nCounter
Prep Station. The reagents in the nCounter Master Kit plates
were added and automated purification began to remove the
excess probes. The targeted probe complexes were then aligned
and immobilized in the nCounter cartridge. The cartridge
was removed from the Prep Station and transferred onto the
nCounter Digital Analyzer. Digital quantitation was done by the
assigned colored barcodes on the surface of the cartridge, which
were counted for each desired target molecule. Finally, a digital
report of the expression quantity of each target gene was given.
Data was analyzed using the nSolver Analysis Software.
RESULTS
Consideration Factors in Sample Selection
Frozen and Formalin-Fixed Paraformaldehyde Embedded
(FFPE) human brain tissues were used to evaluate the RNA
quality. RNA was extracted from three frozen brains and
matched FFPE tissues (same ID#), and RIN was evaluated
(Table 4). All the samples show a large decrease (6.2, 6.5, and
8.3 point of values reduction) of the RIN for FFPE samples
compared to frozen tissues. Therefore, we decided to use frozen
brains for our study.
The PMI, age, and RIN for each of the initial sample set chosen
for quality control (QC) are summarized in Table 5. Applying
TABLE 3 | Probe list.
Gene Position Specificity
ENO 2 1856–1955 Neurons
SYP1 2266–2365 Neurons
SYP2 1341–1440 Neurons
NFLH 1351–1450 Neurons
Synphilin 423–522 Neurons
GFAP 590–689 Astrocytes
B2M 236–335 Housekeeping
SDHA 1448–1547 Housekeeping
LDHA 1691–1790 Housekeeping
CYC1 149–248 Housekeeping
EIF4A2 311–410 Housekeeping
GAPDH 105–204 Housekeeping
YWHAZ 2346–2445 Housekeeping
The position indicates the targeted region within the gene.
rigorous selection criteria, PMI’s were minimized and RINs were
maximized. Only samples with relatively low PMI’s (<13 h)
and high RIN (>4.6) were selected for the final sample cohort.
For example, samples ID #651 and #1600, RIN of 3.6 and 2.9,
respectively, did not pass the QC step and were excluded from
the final sample cohort.
Figure 1 shows the correlation between PMI and RIN and
demonstrates that the two variables have a negative linear
relationship such that increased PMI correlated with smaller RIN
values. Thus, increasing PMI has a negative effect on RIN, and the
correlation is significant enough that PMI should be minimized
to ensure high RNA quality. These findings are in agreement
with previous reports (Birdsill et al., 2011). Accordingly, in our
selection step we excluded samples with PMI >13 h.
Optimizing the Isolation of Specific Cell
Type by Immune-LCM for the Preservation
of the RNA Quality
We identified neurons and astrocytes in normal and diseased
samples by utilizing rapid immunohistochemistry (Figures 2, 3).
We compared the effect of the rapid immunostaining on the
RNA quality under two different conditions: staining at room
temperature and staining on ice. We observed that staining
on ice decreased the RIN by 2 points, while staining at
room temperature caused a decrease of the RIN (>5 points).
Therefore, to preserve the RNA quality, we performed the rapid
immunostaining on ice using cold solutions.
TABLE 4 | QC for frozen and FFPE brain tissues.
ID PMI (h) RIN Tissue
425 5 9.3 Frozen
425 5 1.1 FFPE
1126 2.33 8.8 Frozen
1126 2.33 2.5 FFPE
1690 4.42 6.2 Frozen
1690 4.42 N/A FFPE
TABLE 5 | Sample cohort.
ID PMI (h) RIN
99 2.00 7.4
111 0.60 7.0
247 12.97 5.7
651* 12.40 3.6
673 1.15 8.7
893 5.50 6.8
909 10.61 7.1
963 8.12 6.9
1557 4.00 7.5
1600* 12.97 2.9
*Indicates samples that did not pass the QC step and were excluded from the final sample
cohort.
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Overall, we collected neurons from eight samples and
astrocytes from three samples. Neurons were identified by
Neurofilament immunoreactivity, i.e., positive cells presented
with a golden-brown color differentiating them from the
FIGURE 1 | Correlation between PMI (hours) and RIN values. A linear
model was applied and a coefficient of determination of r2 = 0.49 was
calculated. The plot shows that there is a negative linear relationship between
PMI and RNA quality.
underlying background tissue (Figure 2). Astrocytes were
visualized by GFAP immunoreactivity and also presented with
a golden-brown color (Figure 3). We isolated immunopositive
cells by LCM and catapulted them into an adhesive cap in
a manner that minimized collection of surrounding tissue
(Figures 2, 3). The range number of neurons collected per slide
was 60–200, and on average two slides were used to collect 200
neurons per tissue sample. The PalmRobo software utilized by the
LCM counted the amount of neurons and astrocytes throughout
the isolation step. Slides from which only a small number of
neurons (<60) were identified were discarded.
Using the data generated by nCounter Single Cell Gene
Expression Assay (Nanostring Technologies R©), we evaluated
two parameters relating directly to the immuno-LCM procedure
that potentially may affect the successful accomplishment of the
method: (1) duration of LCM (Figure 4), and (2) days elapsed
between LCM and RNA extraction (Figure 5). We found that
the probability of success, defined as samples that generated an
average count per gene of 4 or more counts, decreased with
increasing duration of these parameters. These results are likely
due to the effect of time-elapse on RNA stability. In accordance
with these results, to increase the probability of success in
obtaining digital expression data, we suggest minimizing LCM
FIGURE 2 | Laser capture microdissection of diseased neurons (A,B) and normal neurons (C,D). Eight micrometers brain tissue sections (temporal cortex)
were stained with anti-Neurofilament antibody. Following rapid immunostaining, the immunoreactive neurons showed a golden-brown color. Neurons were first
visualized and manually selected (A,C). Next, cells were cut and catapulted from the surrounding tissue and collected into an adhesive cap, leaving surrounding tissue
unaffected (B,D). Red arrows indicate neurons before (A,C) and after (B,D) collection. Size bar: 30µm, Magnification: 63X.
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FIGURE 3 | Laser capture microdissection of astrocytes. Eight micrometers brain tissue slides were stained with anti-GFAP antibody. Following rapid
immunostaining, the GFAP-positive cells showed a golden-brown color. Immunoreactive astrocytes were first visualized and manually selected (A,B). Next, astrocytes
were cut and catapulted from the surrounding tissue and collected into an adhesive cap, leaving surrounding tissue unaffected (C,D). Red arrows indicate astrocytes
before (A,C) and after (B,D) collection. Size bar: 30µm, Magnification: 63X.
duration and allowing a maximum time of 120 min to complete
LCM. Additionally, we advise extracting RNA from collected cells
such that the amount of days elapsed between LCM cell collection
and extraction is up to 7–10 days.
Assessment of the Homogeneous Cell
Population: Enrichment in Neuronal Cells
Different neuronal genes (NFLH, ENO2, SYP, Synphilin) have
been used to evaluate the neuronal enrichment. The expression
of seven housekeeping genes (B2M, CYC1, EIF4A2, GAPDH,
LDHA, SDHA, YWHAZ) and GFAP as an astrocyte marker has
been also analyzed. Raw data are reported in Supplementary
Table 1. We selected and analyzed neuronal and housekeeping
genes that show detectable and consistent counts across samples.
Using the data generated by nCounter Single Cell Gene
Expression Assay (Nanostring Technologies R©), we found that
RNA obtained from neurons displayed higher levels of specific
neuronal marker transcripts relative to a calibrator. The
calibrator sample consisted of RNA extracted from a whole
section of normal brain tissue (heterogeneous cell populations).
We evaluated the enrichment of neurons using three neuronal
specific probes: ENO2 and two different probes to identify SYP,
here labeled as SYP 1 and SYP 2. Counts for these neuronal
markers were obtained for all samples and were normalized
relative to the geometric mean of the housekeeping gene counts
for each sample, respectively. The housekeeping genes used
in this study were B2M, LDHA, and SDHA. The selection of
these housekeeping genes was based on the counts obtained:
specifically, we selected genes with high, medium and low counts
(B2M>LDHA>SDHA). Our findings demonstrated neuronal
enrichment in the collected neuron aliquots. Comparison of the
computed relative expression level of each neuronal marker gene
to that of the calibrator is shown in Supplementary Table 2. SYP
2 demonstrated the greatest amount of efficiency and consistency
and was therefore selected as the primary indicator of neuronal
enrichment (Supplementary Tables 2, 3). We considered samples
that showed an increase in SYP2/GFAP ratio of >100-fold
compared to the calibrator to be enriched for neurons (Table 6).
Five samples displayed higher SYP2/GFAP ratio (>100-fold),
while three samples showed lower ratios (<50), indicating that
these cell aliquots were heterogeneous. These three samples were
accordingly excluded from further analysis. In summary, we
validated the isolation of enriched neuronal cells-aliquots by the
immuno-LCMmethod.
Similarly, for the validation of the astrocyte enrichment
we collected 200 astrocytes, GFAP-immunoreactive cells, from
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FIGURE 4 | Probability of success as a function of the duration of LCM.
FIGURE 5 | Probability of success as a function of the average days
elapsed between LCM and RNA extraction.
brain slides of three samples. We compared the levels of
GFAP expression relative to the calibrator (Table 7). The
astrocyte aliquots that show a >7-fold increase in GFAP
expression compared to the calibrator were considered enriched
in astrocytes and selected for further analysis.
Determination of RNA Amplification
Conditions
The total amount of RNA per cell is estimated to be
10 pg, however the expected yield of the procedure due to
manipulations steps is lower than 100%. The initial amount of
RNA we collected from 200 cells was measured in the range of
<1 ng. The nCounter protocol required an input of a total of>50
ng RNA for collection of readable expression data. Therefore,
a step of RNA amplification was necessary. We evaluated the
number of cycles needed to detect mRNA expression in the LCM-
RNA samples and yet remain within the quantitative range. We
perform RNA amplification using three different cycle numbers:
12, 18, and 22. A comparison analysis of the nCounter Single Cell
TABLE 6 | Fold enrichment in neuronal marker compared to the calibrator.
ID *SYP 2/GFAP
SAMPLES SHOWING AN INCREASE IN NEURONAL CONTENT
99 213
247 242
673 256
963 127
1557 408
ID SYP 2/GFAP
SAMPLES SHOWING AN INCREASE IN ASTROCYTE CONTENT
909 3.58
111 38.9
893 36.8
*The values represent the ratios of SYP 2 counts relative to GFAP counts. Each value
indicates the fold increase compared to the calibrator.
TABLE 7 | Fold enrichment in astrocyte marker compared to the calibrator.
ID *GFAP/B2M
ASTROCYTE-SAMPLES INCLUDED IN THE ANALYSIS
1053 18.9
470 7.1
0009 1.78
*The values represent the ratios of GFAP counts relative to B2M counts. Each value
indicates the fold increase compared to the calibrator.
Gene Expression Assay (Nanostring Technologies R©) data using
RNA generated different number of cycles showed that we were
able to detect mRNAusing as little as 12 RNA amplification cycles
and the obtained data using the 12 cycles was consistent and in
the quantitative range.
DISCUSSION
Archived brains from patients and control donors represent a
great resource for studying neurodegenerative diseases. Changes
in gene expression in brain tissues from neurodegenerative
disease patients compared to healthy controls have been reported
(Lewis and Cookson, 2012; Linnertz et al., 2014a,b). However,
the majority of these studies used brain tissue homogenates
that represent multiple cell-types. Gene expression profiles in a
specific population of cells is more informative than studying the
whole tissue, particularly in the brain, where different pathologies
affect a specific subset of cells (Saxena and Caroni, 2011;
Jackson, 2014). Due to the difficulty in obtaining homogenous
cell population, gene expression in specific cell-types (neurons,
glial-types) has been understudied. Thus, the specific cell-type
responsible for the observed alteration in expression levels
remained largely elusive. The method that we described provides
the possibility to isolate cells from frozen brain tissue and study
the gene expression in specific cells relevant to the disease of
interest under physiological and pathological conditions.
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RNA quality and quantity are key factors in obtaining
reliable and reproducible data of gene expression. Several factors
impact the RNA quality amongst the quality of post-mortem
tissue. While the quality of the archived tissues is measured
by different parameters, RIN is widely considered a reliable
measure of the quality of material for gene expression studies.
We showed that tissue manipulation steps compromise the
RNA integrity, therefore, samples recommended for use in
performance of the described protocol should demonstrate high
RIN values (>7) prior to the manipulation steps of the method.
Furthermore, to preserve the RNA quality, we optimized the
rapid immunostaining on ice under RNAse-free conditions.
Other factors that affect the RNA stability were examined as
well. We observed that the factors such as the duration of LCM
and days elapsed between LCM, and RNA extraction determined
the successful performance of the technique. We found that the
probability of success decreased with increasing duration of these
parameters that are likely to affect the RNA stability.
For the RNA analysis described here, we used the nCounter
Single Cell Gene Expression Assay that allows the generation
of detectable and quantitative gene expression data from single
cells or as little as 10 pg of RNA. However, small amount of
RNA (<50 ng) requires a MTE amplification step (McDavid
et al., 2014; Liao et al., 2016; Slichter et al., 2016). It has been
shown that the MTE amplification step doesn’t introduce any
bias in a comparison analysis of a sample that underwent the
MTE step and a brain total RNA as sample input. Moreover,
we optimized the number of cycles (to as little as 12 cycles) so
that background levels wouldn’t affect the gene expression raw
data and remains in the quantitative range. Different approaches
are available for gene expression studies: i.e., fluorescence in
situ hybridization, single cell quantitative real-time PCR, and
microarrays. The in situ hybridization technique is prone to
false positive results due to non-specific binding of the probes.
Moreover, only fairly abundant mRNA can be detected using this
technique. PCR-based techniques require substantial amounts
of amplification cycles to allow the detection from RNA input
extracted from single cells. Microarrays enable measurements
of thousands of genes at once from single cells. However, small
RNA input (<200 ng) requires amplification step, which might
introduce bias and non-specific products (Croner et al., 2009).
Therefore, the nCounter Single Cell Gene Expression Assay is
most suitable for the purposes of the method developed here.
The ability to analyze cell populations is incredibly important
to neurological research, since neurodegenerative disease
processes are fundamentally cell-type specific. Traditionally, the
use of whole tissue homogenates to study neurodegenerative
diseases is effective, yet excludes the integral role that cell types
provide individually. Subtle variations in gene expression will
be missed in the analysis of heterogeneous cell population.
Our dissimilar approach allows for the analysis of results that
are more representative of cell-type specific disease etiology,
and increases the sensitivity of gene expression profiling of
homogenous cells, thus improving the evaluation of subtle
variation. However, the method described here has some
limitations compared to gene expression analysis of whole
tissue homogenates. Tissue manipulation compromises the
quality of RNA to a greater extent compared to the analysis of
whole tissue homogenates. The procedure is time consuming,
which impacts the feasibility to analyze a large sample size.
Lastly, the analyzed samples are enriched for a specific cell-type,
however traces of contamination with other cells should be
considered in the data analysis. For example, we assessed the
specificity of the collected cell type by evaluating the enrichment
of neurons using two neuronal specific markers: ENO2 and
SYP. The expression of these genes were normalized relative to
the geometric mean of three housekeeping genes: B2M, LDHA,
and SDHA. The enrichment of each sample was compared to
the relative expression level of each neuronal marker to that of
the calibrator (aliquot of heterogeneous cells). We considered
samples that showed an increase in SYP2/GFAP ratio >100-fold
compared to the calibrator, to be enriched for neurons. We
also collected homogenous aliquots of astrocytes and examined
their enrichment by evaluating the expression of GFAP. GFAP
is a widely accepted marker for astrocytes (Middeldorp and
Hol, 2011). Samples that show an enrichment of at least 7-fold
compared to the calibrator, were included in downstream
analysis. The cell aliquots obtained are highly enriched for a
specific cell-type and provide a sufficient amount of RNA for
cell-specific gene expression analysis.
Our new method represents an advancement compared to
previous methods. Methods reported previously (Waller et al.,
2012) perform the rapid immunostaining at room temperature.
We optimized the rapid immunostaining on ice under RNase-
free conditions to better preserve the RNA integrity. Additional
improvement concerns the lower number of cells that can be
collected and show robust expression results. While previous
methods collected a minimum of 1000 cells, we show that the
collection of 200 cells is sufficient to obtain consistent and
reliable results. This greatly increases procedure feasibility not
only by decreasing the amount of time required for cell collection,
but also reducing the number of tissue slides to be used.
Additionally, coupling nCounter Single Cell Gene Expression
assay (Nanostring Technologies R©) as a downstream application
of the immune-LCM procedure presents a novel approach in
the research of neurodegenerative disease. Therefore, the method
described here introduces novel improvements that are of great
interest to members of the neuroscience community.
The immune-LCM technique coupled with the nCounter
Single Cell Gene Expression Assay (Nanostring Technologies R©)
developed here, will advance the understanding of the neuronal
vs. astroglia-specific processes involved in the development of
neurodegenerative diseases. The method can be implemented
in a broader range of molecular analyses in addition to gene
expression and is potentially applicable for studies of other
diseases in which specific cell-type is affected.
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